BCF Life Sciences: an SME listened to right up to the Senate and the Elysée!

BCF Life Sciences au Sénat

Making the voice of businesses heard is absolutely essential and we are fortunate to be a recognized and listened-to SME thanks to our sustained growth, job creation (120 jobs created since 2008) and our voluntary investment policy (between 5 and 7 million industrial investments each year).

As such, we are constantly working to explain the challenges that French SMEs must face in international competition.
In this context, Jacques Pidoux spoke on April 12 alongside France Chimie and the companies Arkema and Seqens during a hearing before the Senate’s Economic Committee and went to the Elysée Palace on April 14 with Henri Lagarde to meet with the office of the President of the Republic.

On the menu of these interviews: the challenges of competitiveness for SMEs and the reforms that are essential to initiate or accelerate, particularly with regard to production taxation and the administrative delays that are still far too long to conduct industrial establishment projects in France.